Sivelestat significantly reduced the incidence of postoperative ARDS, lowered 90-day mortality, and suppressed inflammatory biomarkers linked to lung injury.
A systematic review detailed how chronic kidney disease (CKD) imposes substantial financial, productivity, and quality-of-life burdens on both patients and their informal caregivers in the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results